BioBusiness

Articles

Evonik and Stanford University have signed a research collaboration to develop and market a new drug delivery platform for mRNA and gene therapy.

Evonik and Stanford University Partner to Develop mRNA Drug Delivery Technology

Optima has teamed up with the Robert-Bosch-Krankenhaus and Heidelberg University to develop a unit for decentralized, automated production of CAR-T cell therapies.

Optima Teams Up with Clinics to Develop Production Unit for CAR-T Cell Therapies

AGC Biologics has partnered with BioNTech to further supply plasmid DNA starting material from its Heidelberg, Germany, facility for the Pfizer-BioNTech COVID-19 vaccine.

AGC Biologics to Supply More Plasmid DNA for Pfizer-BioNTech COVID-19 Vaccine

As COVID-19 continues to spread, industry leaders are banding together to stop the disease in its tracks. 

Industry Consortiums Work to Tackle COVID-19

The companies are expanding their collaboration to extend the drug substance manufacturing of Moderna’s COVID-19 vaccine with the addition of a new manufacturing line at Lonza’s Geleen, Netherlands, site. 

Lonza and Moderna to Expand Their COVID-19 Vaccine Drug Substance Manufacturing Collaboration

Moderna and Aldevron have expanded their existing collaboration to support Moderna’s COVID-19 vaccine program as well as additional clinical programs in Moderna’s pipeline.

Moderna and Aldevron Expand Partnership for mRNA Vaccine and Therapeutic Pipeline

Biogen and Ginkgo Bioworks have partnered to develop a next-generation AAV production platform to accelerate Biogen’s gene therapy drug development efforts.

Biogen and Ginkgo Bioworks in $120-Million Deal to Develop Novel Gene Therapy Manufacturing Platform

Codagenix and Univercells have partnered on a research collaboration to pursue an undisclosed, high-priority human vaccine target.

Codagenix and Univercells Collaborate on Vaccine Research for Undisclosed Target

Samsung Biologics plans to support the production of hundreds of millions of doses of Moderna’s vaccine to supply to markets outside of the United States beginning in the third quarter of 2021. 

Moderna and Samsung Biologics Partner on Fill/Finish Manufacturing of Moderna’s COVID-19 Vaccine

Under the terms of the agreement, Thermo Fisher will construct and operate a 44,000-ft2 cell therapy development, manufacturing, and collaboration center on UCSF's Mission Bay campus.

Partnerships